Approval was given to GSK, making its product the first antisense oligonucleotide established for the treatment of chronic hepatitis B.
News|Articles|October 6, 2003
In gestation: New OTC reproductive health products
Instead Inc. launches several new OTC products, including a disposable diaphragm and non-greasy seaweed-based vaginal lubricant gel.
Advertisement
Advertisement
Related to this article
With safety and efficacy profiles aligning with its brand-name formulation, this new patch could be key for women struggling with hormone therapy adherence.
Therapy is aimed at decreasing pathogenic IgA production and immune complex formation as well as managing the effects of existing nephron loss.
This new, nonprescription therapy expands eye relief options for patients in need of apraclonidine eye drop formulations.
Advertisement
Advertisement
Trending on Drug Topics
1
COVID-19 Vaccine Lowers Venous Thromboembolism, Mortality Risk
2
PBMs Must Now Disclose Fees to Employer Plans Under Final DOL Rule
3
American Pharmacists Month: Pharmacists as Care Team Partners Fuels Optimism for the Profession
4
Pharmacies Face Persistent MFP Cash Crunch Amid PBM, 340B Shifts
5